杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/07/27 | 1,637 | 1,643 | 1,624 | 1,638 | +8 | +0.5% | 90,000 |
2011/07/26 | 1,638 | 1,639 | 1,626 | 1,630 | -14 | -0.9% | 96,000 |
2011/07/25 | 1,636 | 1,661 | 1,625 | 1,644 | +19 | +1.2% | 128,000 |
2011/07/22 | 1,626 | 1,635 | 1,624 | 1,625 | +1 | +0.1% | 94,000 |
2011/07/21 | 1,628 | 1,630 | 1,614 | 1,624 | -11 | -0.7% | 108,000 |
2011/07/20 | 1,650 | 1,658 | 1,630 | 1,635 | -11 | -0.7% | 148,000 |
2011/07/19 | 1,623 | 1,652 | 1,617 | 1,646 | +2 | +0.1% | 152,000 |
2011/07/15 | 1,631 | 1,648 | 1,631 | 1,644 | +13 | +0.8% | 182,000 |
2011/07/14 | 1,665 | 1,665 | 1,618 | 1,631 | -49 | -2.9% | 285,000 |
2011/07/13 | 1,640 | 1,692 | 1,640 | 1,680 | +40 | +2.4% | 273,000 |
2011/07/12 | 1,636 | 1,651 | 1,631 | 1,640 | -15 | -0.9% | 159,000 |
2011/07/11 | 1,628 | 1,663 | 1,628 | 1,655 | +28 | +1.7% | 240,000 |
2011/07/08 | 1,623 | 1,633 | 1,621 | 1,627 | +4 | +0.2% | 117,000 |
2011/07/07 | 1,633 | 1,633 | 1,613 | 1,623 | -18 | -1.1% | 179,000 |
2011/07/06 | 1,600 | 1,649 | 1,595 | 1,641 | +63 | +4% | 442,000 |
2011/07/05 | 1,560 | 1,582 | 1,560 | 1,578 | +6 | +0.4% | 82,000 |
2011/07/04 | 1,589 | 1,589 | 1,571 | 1,572 | -7 | -0.4% | 88,000 |
2011/07/01 | 1,590 | 1,590 | 1,569 | 1,579 | -19 | -1.2% | 200,000 |
2011/06/30 | 1,595 | 1,599 | 1,585 | 1,598 | +10 | +0.6% | 126,000 |
2011/06/29 | 1,579 | 1,594 | 1,574 | 1,588 | +10 | +0.6% | 143,000 |
2011/06/28 | 1,560 | 1,578 | 1,555 | 1,578 | +37 | +2.4% | 191,000 |
2011/06/27 | 1,546 | 1,554 | 1,514 | 1,541 | -22 | -1.4% | 201,000 |
2011/06/24 | 1,592 | 1,600 | 1,552 | 1,563 | +11 | +0.7% | 287,000 |
2011/06/23 | 1,540 | 1,558 | 1,540 | 1,552 | -5 | -0.3% | 145,000 |
2011/06/22 | 1,535 | 1,571 | 1,532 | 1,557 | +12 | +0.8% | 112,000 |
2011/06/21 | 1,555 | 1,560 | 1,537 | 1,545 | +4 | +0.3% | 124,000 |
2011/06/20 | 1,527 | 1,549 | 1,520 | 1,541 | +37 | +2.5% | 133,000 |
2011/06/17 | 1,538 | 1,540 | 1,504 | 1,504 | -45 | -2.9% | 274,000 |
2011/06/16 | 1,556 | 1,565 | 1,539 | 1,549 | -20 | -1.3% | 156,000 |
2011/06/15 | 1,576 | 1,578 | 1,552 | 1,569 | -17 | -1.1% | 193,000 |
2011/06/14 | 1,574 | 1,590 | 1,573 | 1,586 | +11 | +0.7% | 88,000 |
2011/06/13 | 1,571 | 1,586 | 1,566 | 1,575 | +4 | +0.3% | 66,000 |
2011/06/10 | 1,603 | 1,603 | 1,565 | 1,571 | -21 | -1.3% | 238,000 |
2011/06/09 | 1,563 | 1,592 | 1,563 | 1,592 | +25 | +1.6% | 197,000 |
2011/06/08 | 1,550 | 1,570 | 1,547 | 1,567 | +17 | +1.1% | 94,000 |
2011/06/07 | 1,540 | 1,550 | 1,540 | 1,550 | +10 | +0.6% | 124,000 |
2011/06/06 | 1,538 | 1,544 | 1,528 | 1,540 | +2 | +0.1% | 129,000 |
2011/06/03 | 1,534 | 1,541 | 1,517 | 1,538 | +3 | +0.2% | 257,000 |
2011/06/02 | 1,534 | 1,541 | 1,526 | 1,535 | -10 | -0.6% | 108,000 |
2011/06/01 | 1,530 | 1,545 | 1,526 | 1,545 | +15 | +1% | 187,000 |
2011/05/31 | 1,545 | 1,547 | 1,530 | 1,530 | -14 | -0.9% | 271,000 |
2011/05/30 | 1,530 | 1,545 | 1,520 | 1,544 | +7 | +0.5% | 86,000 |
2011/05/27 | 1,543 | 1,545 | 1,534 | 1,537 | -8 | -0.5% | 114,000 |
2011/05/26 | 1,550 | 1,564 | 1,541 | 1,545 | -8 | -0.5% | 193,000 |
2011/05/25 | 1,550 | 1,555 | 1,530 | 1,553 | +23 | +1.5% | 221,000 |
2011/05/24 | 1,506 | 1,530 | 1,500 | 1,530 | +24 | +1.6% | 147,000 |
2011/05/23 | 1,493 | 1,514 | 1,484 | 1,506 | +13 | +0.9% | 215,000 |
2011/05/20 | 1,489 | 1,508 | 1,485 | 1,493 | -15 | -1% | 182,000 |
2011/05/19 | 1,488 | 1,516 | 1,480 | 1,508 | +20 | +1.3% | 294,000 |
2011/05/18 | 1,484 | 1,502 | 1,484 | 1,488 | +3 | +0.2% | 122,000 |
3351~
3400
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 136,500円 | +3.2% | +4.5% | 3.81% | 15.68倍 | 0.60倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 290,300円 | +3.0% | +27.5% | 2.76% | 18.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 138,800円 | - | - | 0.00% | - | 64.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 201,200円 | +0.4% | -8.4% | 2.63% | 25.83倍 | 1.46倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム